No child should die from type 1 diabetes
We are expanding our Changing Diabetes® in Children programme to
reach 100,000 children by 2030. Already, our programme has helped more
than 25,000 children with type 1 diabetes get access to medical care
and life-saving medicine in low-resource settings.
Affordable human insulin in low- and middle-income countries
We are reducing the ceiling price of human insulin from USD 4 to
USD 3 per vial in 76 low- and middle-income countries. This is a
vital expansion of our Access to Insulin Commitment to strengthen
our efforts to reach the most vulnerable people with low-cost insulin.
Improved care for vulnerable populations
We are extending our Partnering for Change programme with the
International Committee of the Red Cross and the Danish Red Cross
until 2023, and supporting with a donation of DKK 15 million. Through
our joint efforts, the programme helps the most vulnerable patient
groups during humanitarian crises.